Does the Time of Postoperative Bisphosphonate Administration Affect the Bone Union in Osteoporotic Intertrochanteric Fracture of Femur?
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: This study was designed to investigate the effect of bisphosphonate administration starting time on bone healing and to identify the best administration time following surgical treatment of osteoporotic intertrochanteric fractures. Materials and Methods: Two hundreds and eighty four patients (284 hips; 52 males, 232 females) who underwent surgery following osteoporotic intertrochanteric fracture from December 2002 to December 2012 were retrospectively analyzed. The average follow-up period was 68.4 months. The patients were divided into three groups according to the time of bisphosphonate administration after operation: 1 week (group A; n=102), 1 month (group B; n=89), and 3 months (group C; n=93). Koval scores and change of Koval scores 1 year after operation were used for clinical evaluation. For radiologic evaluation, the time of callus appearance across the fracture line on sagittal and coronal radiographs and the time to absence of pain during hip motion was judged as the time of bone union. Results: Koval scores one year after surgery for groups A, B, and C were 2.44, 2.36, and 2.43 (P=0.895), respectively. The mean time of union was 12.4, 11.9, and 12.3 weeks after operation in the three groups (P=0.883), respectively. There were zero cases of nonunion. There were 3, 5, and 7 cases of fixative displacement in the three groups, respectively, but the distribution showed no significant difference (P>0.472). Conclusion: The initiating time of bisphosphonate administration following surgery does not affect the clinical outcomes in patients with osteoporotic intertrochanteric fracture.
Abstract
Purpose: This study was designed to investigate the effect of bisphosphonate administration starting time on bone healing and to identify the best administration time following surgical treatment of osteoporotic intertrochanteric fractures. Materials and Methods: Two hundreds and eighty four patients (284 hips; 52 males, 232 females) who underwent surgery following osteoporotic intertrochanteric fracture from December 2002 to December 2012 were retrospectively analyzed. The average follow-up period was 68.4 months. The patients were divided into three groups according to the time of bisphosphonate administration after operation: 1 week (group A; n=102), 1 month (group B; n=89), and 3 months (group C; n=93). Koval scores and change of Koval scores 1 year after operation were used for clinical evaluation. For radiologic evaluation, the time of callus appearance across the fracture line on sagittal and coronal radiographs and the time to absence of pain during hip motion was judged as the time of bone union. Results: Koval scores one year after surgery for groups A, B, and C were 2.44, 2.36, and 2.43 (P=0.895), respectively. The mean time of union was 12.4, 11.9, and 12.3 weeks after operation in the three groups (P=0.883), respectively. There were zero cases of nonunion. There were 3, 5, and 7 cases of fixative displacement in the three groups, respectively, but the distribution showed no significant difference (P>0.472). Conclusion: The initiating time of bisphosphonate administration following surgery does not affect the clinical outcomes in patients with osteoporotic intertrochanteric fracture.
참고문헌 (32)
- Murakami H, "A possible mechanism of the specific action of bisphosphonates on osteoclasts : tiludronate preferentially affects polarized osteoclasts having ruffled borders", Bone, 17, pp.137~144 (1995)
- Sato M, "Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy", J Bone Miner Res, 5, pp.31~40 (1990)
- Bartl R, "Update 2004. Osteoporosis--management--current status", Krankenpfl J, 42, pp.232~ (2004)
- Shin CS, "Prevalence and risk factors of osteoporosis in Korea : a community-based cohort study with lumbar spine and hip bone mineral density", Bone, 47, pp.378~387 (2010)
- Solomon DH, "The relation between bisphosphonate use and non-union of fractures of the humerus in older adults", Osteoporos Int, 20, pp.895~901 (2009)
- Davidson CW, "Hip fracture mortality and morbidity--can we do better?", N Z Med J, 114, pp.329~332 (2001)
- 이성락, "고관절 주위골절로 인한 사망률 및 활동성 -전향적 연구-", 대한정형외과학회지, 40(4), pp.423~427 (2005), 대한정형외과학회
- 문은수, "The Incidence of New Vertebral Compression Fractures in Women after Kyphoplasty and Factors Involved", Yonsei Medical Journal, 48(4), pp.645~652 (2007), 연세대학교의과대학
- 윤형구, "고령에서 시간을 달리한 양측 고관절 주위 골절의 임상 형태", 대한골절학회지, 18(4), pp.375~378 (2005), 대한골절학회
- Gardner MJ, "Improvement in the undertreatment of osteoporosis following hip fracture", J Bone Joint Surg Am, 84(A), pp.1342~1348 (2002)
- 하용찬, "제주도 지역 고관절 주위골절에 대한 역학연구", 대한정형외과학회지, 39(2), pp.131~136 (2004), 대한정형외과학회
- 임수재, "고관절 주위 골절 후에 골다공증 치료의 결과", 대한골절학회지, 23(2), pp.167~171 (2010), 대한골절학회
- Li J, "Effect of bisphosphonate(incadronate)on fracture healing of long bones in rats", J Bone Miner Res, 14, pp.969~979 (1999)
- Li C, "Long-term effect of incadronate disodium(YM-175)on fracture healing of femoral shaft in growing rats", J Bone Miner Res, 16, pp.429~436 (2001)
- Bauss F, "New model for simulation of fracture repair in fullgrown beagle dogs : model characterization and results from a long-term study with ibandronate", J Pharmacol Toxicol Methods, 50, pp.25~34 (2004)
- Munns CF, "Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate", J Bone Miner Res, 19, pp.1779~1786 (2004)
- Rozental TD, "Comparison of radiographic fracture healing in the distal radius for patients on and off bisphosphonate therapy", J Hand Surg Am, 34, pp.595~602 (2009)
- Amanat N, "A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair", J Orthop Res, 23, pp.1029~1034 (2005)
- Goodship AE, "Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone", Ann Oncol, 5(Suppl 7), pp.S53~S55 (1994)
- Little DG, "Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model", J Bone Miner Res, 20, pp.2044~2052 (2005)
- Bransford R, "Effect of zoledronic acid in an L6-L7 rabbit spine fusion model", Eur Spine J, 16, pp.557~562 (2007)
- Xu XL, "Basic research and clinical applications of bisphosphonates in bone disease:what have we learned over the last 40 years?", J Transl Med, 11, pp.303~ (2013)
- Odvina CV, "Unusual mid-shaft fractures during long-term bisphosphonate therapy", Clin Endocrinol(Oxf), 72, pp.161~168 (2010)
- Ha YC, "Is surgery necessary for femoral insufficiency fractures after longterm bisphosphonate therapy?", Clin Orthop Relat Res, 468, pp.3393~3398 (2010)
- Weil YA, "The outcome of surgically treated femur fractures associated with long-term bisphosphonate use", J Trauma, 71, pp.186~190 (2011)
- Bobyn JD, "Zoledronic acid causes enhancement of bone growth into porous implants", J Bone Joint Surg Br, 87, pp.416~420 (2005)
- Molvik H, "Bisphosphonates and their influence on fracture healing : a systematic review", Osteoporos Int, 26, pp.1251~1260 (2015)
- Shane E, "Atypical subtrochanteric and diaphyseal femoral fractures : second report of a task force of the American Society for Bone and Mineral Research", J Bone Miner Res, 29, pp.1~23 (2014)
- Gong HS, "Early initiation of bisphosphonate does not affect healing and outcomes of volar plate fixation of osteoporotic distal radial fractures", J Bone Joint Surg Am, 94, pp.1729~1736 (2012)
- Abrahamsen B, "Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate : a register-based national cohort study", J Bone Miner Res, 24, pp.1095~1102 (2009)
- Harris LJ, "Implant failures in orthopaedic surgery", Biomater Med Devices Artif Organs, 7, pp.243~255 (1979)
- Koval KJ, "Hip fractures: II. Evaluation and treatment of intertrochanteric fractures", J Am Acad Orthop Surg, 2, pp.150~156 (1994)